Fin, Kent Reo .

HRN: 09-58-21  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2022
CEFUROXIME 750MG (VIAL)
10/01/2022
10/08/2022
IVT
750mg
Q8
Uti
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: